These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21907861)

  • 1. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial.
    Powell H; Murphy VE; Taylor DR; Hensley MJ; McCaffery K; Giles W; Clifton VL; Gibson PG
    Lancet; 2011 Sep; 378(9795):983-90. PubMed ID: 21907861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.
    Murphy VE; Jensen ME; Mattes J; Hensley MJ; Giles WB; Peek MJ; Bisits A; Callaway LK; McCaffery K; Barrett HL; Colditz PB; Seeho SK; Attia J; Searles A; Doran C; Powell H; Gibson PG
    BMC Pregnancy Childbirth; 2016 May; 16():111. PubMed ID: 27189595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
    Martinez FJ; Calverley PM; Goehring UM; Brose M; Fabbri LM; Rabe KF
    Lancet; 2015 Mar; 385(9971):857-66. PubMed ID: 25684586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study.
    Haahtela T; Tamminen K; Malmberg LP; Zetterström O; Karjalainen J; Ylä-Outinen H; Svahn T; Ekström T; Selroos O
    Eur Respir J; 2006 Oct; 28(4):748-55. PubMed ID: 17012630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
    Smith AD; Cowan JO; Brassett KP; Herbison GP; Taylor DR
    N Engl J Med; 2005 May; 352(21):2163-73. PubMed ID: 15914548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.
    Szefler SJ; Mitchell H; Sorkness CA; Gergen PJ; O'Connor GT; Morgan WJ; Kattan M; Pongracic JA; Teach SJ; Bloomberg GR; Eggleston PA; Gruchalla RS; Kercsmar CM; Liu AH; Wildfire JJ; Curry MD; Busse WW
    Lancet; 2008 Sep; 372(9643):1065-72. PubMed ID: 18805335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial.
    Syk J; Malinovschi A; Johansson G; Undén AL; Andreasson A; Lekander M; Alving K
    J Allergy Clin Immunol Pract; 2013; 1(6):639-48.e1-8. PubMed ID: 24565712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
    Gibson PG; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Marks GB; Baraket M; Powell H; Taylor SL; Leong LEX; Rogers GB; Simpson JL
    Lancet; 2017 Aug; 390(10095):659-668. PubMed ID: 28687413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.
    Kharitonov SA; Donnelly LE; Montuschi P; Corradi M; Collins JV; Barnes PJ
    Thorax; 2002 Oct; 57(10):889-96. PubMed ID: 12324677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
    Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractioned exhaled nitric oxide (FE(NO)) is not a sufficiently reliable test for monitoring asthma in pregnancy.
    Nittner-Marszalska M; Liebhart J; Pawłowicz R; Kazimierczak A; Marszalska H; Kraus-Filarska M; Panaszek B; Dor-Wojnarowska A
    Nitric Oxide; 2013 Sep; 33():56-63. PubMed ID: 23756211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.
    Shaw DE; Berry MA; Thomas M; Green RH; Brightling CE; Wardlaw AJ; Pavord ID
    Am J Respir Crit Care Med; 2007 Aug; 176(3):231-7. PubMed ID: 17496226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-guided management reduces exacerbations in non-eosinophilic asthma in pregnancy: A secondary analysis of a randomized controlled trial.
    Murphy VE; Porsbjerg CM; Robijn AL; Gibson PG
    Respirology; 2020 Jul; 25(7):719-725. PubMed ID: 31656059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.